Trial Condition(s):
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
16973
Not Available
Not Available
The Essure System is indicated for women who desire non-incisional permanent birth control (female sterilization) by occlusion of the fallopian tubes. The objective of the study is to evaluate the safety and effectiveness of the Essure System (Model ESS505) for permanent birth control in preventing pregnancy. The Essure ESS505 System includes a design modification that will be studied to determine if it provides immediate birth control, thereby removing the three months waiting period required for the commercially available Essure System Model 305 to be effective.
- Female, 21 to 44 years of age, inclusive - Body weight within range of 90-300 lbs (40 – 136 kg) - Sexually active (minimum of 4 coital acts per cycle) - Willing to accept the risk of pregnancy while relying solely on the inserts for contraception - Medical history indicates bilateral viable and patent fallopian tubes - Agrees to fulfill local requirements for counseling and consent to contraception and sterilization, including any required waiting periods
- Post-menopausal woman - Suspected or confirmed pregnancy - Post-partum or pregnancy termination ≤6 weeks of scheduled insert placement - Past fallopian tube sterilization procedure and/or total or partial salpingectomies - Diagnosis of any of the following: tubal, endometrial, or myometrial pathology (which may prevent fallopian tube ostia access), proximal tubal occlusion in either fallopian tube, unicornuate uterus, active or recent upper or lower pelvic infection, gynecologic malignancy - Currently taking corticosteroids - Known allergy to all contrast media available for use in hysterosalpingogram - Scheduled to undergo concomitant intrauterine procedures at the time of insert placement (intrauterine device removal is not considered a concomitant procedure) - Any general health condition or systemic disease that may represent, in the opinion of the physician, a potential increased risk associated with device use or pregnancy
Locations | |
---|---|
Locations Investigative Site Bronx, United States, 10467 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Spokane, United States, 99204 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Newburgh, United States, 47630 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Houston, United States, 77074 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Fort Wayne, United States, 46825 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site New York, United States, 10019 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Asheville, United States, 28801 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Córdoba, Spain, 14004 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Hamilton, Canada, L8N 3Z5 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site ZWOLLE, Netherlands, 8025 AB | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site L'Hospitalet de llobregat, Spain, 08906 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Dallas, United States, 75208 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Arlington Heights, United States, 60004 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Regina, Canada, S4S 6X3 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Cincinnati, United States, 45231 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Aurora, United States, 80045 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Norfolk, United States, 23507 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Rochester, United States, 55905 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Saginaw, United States, 48604 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Boynton Beach, United States, 33472-2952 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Irving, United States, 75062 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Aurora, United States, 80012 | Contact Us: E-mail: [email protected] Phone: Not Available |
A Multi-Center, Multi-National Clinical Study to Evaluate the Safety and Effectiveness of the Essure® (Model ESS505) Device to Prevent Pregnancy in Women Who Are Seeking Permanent Contraception
Trial Type:
Interventional
Intervention Type:
Device
Trial Purpose:
Prevention
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1